These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17291140

  • 1. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway.
    Stillman MJ, Stillman MT.
    Geriatrics; 2007 Feb; 62(2):26-34. PubMed ID: 17291140
    [Abstract] [Full Text] [Related]

  • 2. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ, Stillman MT.
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [Abstract] [Full Text] [Related]

  • 3. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C, Chan AT, Tramontano AC, Gazelle GS.
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT, Pucino F, Resman-Targoff BH.
    J Pain Palliat Care Pharmacother; 2006 Jun; 20(4):11-32. PubMed ID: 17182503
    [Abstract] [Full Text] [Related]

  • 5. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H, Bombardier C, Davis P, Russell AS, Third Canadian Consensus Conference Group.
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [Abstract] [Full Text] [Related]

  • 6. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L.
    Rev Gastroenterol Disord; 2004 Jan; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [Abstract] [Full Text] [Related]

  • 7. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF, Buchanan WW.
    Inflammopharmacology; 2005 Jan; 13(4):343-70. PubMed ID: 16354389
    [Abstract] [Full Text] [Related]

  • 8. Coxibs: Evolving role in pain management.
    Katz N.
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [Abstract] [Full Text] [Related]

  • 9. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
    Bolten WW.
    MMW Fortschr Med; 2005 Aug 04; 147(31-32):24-7. PubMed ID: 16128192
    [Abstract] [Full Text] [Related]

  • 10. [Is there a future for COX-2 inhibitors?].
    Yodfat Y.
    Harefuah; 2004 Nov 04; 143(11):820-4, 837. PubMed ID: 15603272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA, Derry S, Phillips CJ, McQuay HJ.
    BMC Musculoskelet Disord; 2006 Oct 20; 7():79. PubMed ID: 17054784
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ, Islam K.
    J Physiol Pharmacol; 2008 Aug 20; 59 Suppl 2():117-33. PubMed ID: 18812633
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
    Haag MD, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH.
    Arch Intern Med; 2008 Jun 09; 168(11):1219-24. PubMed ID: 18541831
    [Abstract] [Full Text] [Related]

  • 16. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep 09; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

  • 17. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A, Hunt R.
    Ann Med; 2006 Sep 09; 38(6):415-28. PubMed ID: 17008305
    [Abstract] [Full Text] [Related]

  • 18. Nonsteroidal gastropathy in dentistry--issues and controversies in patient's management.
    Afolabi AO, Adekanle OA.
    Niger J Med; 2009 Sep 09; 18(1):39-42. PubMed ID: 19485146
    [Abstract] [Full Text] [Related]

  • 19. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA, Khan NK.
    Exp Toxicol Pathol; 2006 Nov 09; 58(2-3):163-73. PubMed ID: 16859903
    [Abstract] [Full Text] [Related]

  • 20. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C.
    Bull Cancer; 2004 May 09; 91 Suppl 2():S125-31. PubMed ID: 15899637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.